627076-46-4 Usage
Uses
Used in Pharmaceutical Drug Development:
1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile is used as a potential candidate in the development of pharmaceutical drugs for various medical conditions. Its unique molecular structure and the presence of a carbonitrile functional group make it an interesting compound for researchers to explore its potential uses and effects in drug discovery and development.
Used in Medicinal Chemistry Research:
1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile is used as a subject of study in medicinal chemistry research to investigate its potential biological and pharmacological properties. 1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile's structure and functional groups may provide insights into its interactions with biological targets, which could lead to the development of new therapeutic agents.
Used in Drug Discovery:
1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile is used as a starting point in drug discovery efforts. Its unique molecular structure and the presence of a carbonitrile functional group make it a valuable compound for researchers to explore its potential as a lead compound in the development of new drugs for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 627076-46-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,0,7 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 627076-46:
(8*6)+(7*2)+(6*7)+(5*0)+(4*7)+(3*6)+(2*4)+(1*6)=164
164 % 10 = 4
So 627076-46-4 is a valid CAS Registry Number.
627076-46-4Relevant academic research and scientific papers
RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
-
Paragraph 0433; 0434; 0435; 0436; 0527 - 0530, (2014/12/09)
The present application relates to novel fused pyrimidines and triazines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
3-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use Thereof
-
, (2010/05/13)
The present application relates to novel 3-tetrazolylindazole and 3-tetrazolylpyrazolo[3,4-b]-pyridine derivatives, processes for their preparation, their use alone or in combination for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
-
Page/Page column 18, (2010/02/16)
The present application relates to novel heterocyclyl-substituted fused pyrazole derivatives, to processes for their preparation, to their use, alone or in combination, for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
